Jackson Watke

Vanderbilt University Medical Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

2h-index11citations20works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Histone Deacetylase Inhibitors Research(18), Protein Degradation and Inhibitors(18), Cancer-related gene regulation(10), Acute Myeloid Leukemia Research(7), CRISPR and Genetic Engineering(2)

Publications20 total

Interallelic gene conversion of leukemia-associated single nucleotide variants
Gene·2025· 2 citedOpen Access
Repair of leukemia-associated single nucleotide variants via interallelic gene conversion
2024Open Access
Figure S4 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Table S2 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Figure S3 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Figure S2 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Table S2 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Data from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Data from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Table S1 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Figure S4 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Figure S5 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Figure S1 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Figure S1 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Figure S2 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Figure S3 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Table S1 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Figure S5 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024Open Access
Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
Cancer Research·2024· 9 citedOpen Access
Lactate Utilization Provides a Metabolic Escape to Resist the Antileukemic Activity of BET Inhibition in Acute Myeloid Leukemia
Blood·2022

Frequent Co-authors

Haley E. Ramsey(20), Alexander J. Silver(20), Donovan Brown(20), Sarah D. Olmstead(20), Agnieszka E. Gorska(20), Michael R. Savona(20), Andrew J. Monteith(18), Dalton Greenwood(18), Maria P. Arrate(18), Jeffrey C. Rathmell(18), Brianna N. Smith(17), Ashley D. Wise(17), Juan Liu(17), Londa Fuller(17), Jason W. Locasale(17), Matthew C. Stubbs(17), Londa Tanner(2), Londa S. Fuller(1), Matthew Stubbs(1)